Here's Wouldn't Touch Moderna: Why I Won't Bet on Its Next Growth Engine
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Choosing the right rewards program can significantly impact your benefits. Learn which one suits you best.
27,761 articlesModerna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Two consumer brands buck a slowing staples backdrop, delivering growth driven by more transactions and expanded house...
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
AI sparks a data deluge, and storage stocks ride the wave. This guide breaks down how this storage stock more opportu...
A high-profile journey to one of the world’s largest refugee camps shines a light on refugees’ needs and the money be...
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
Anthropic confirms it is testing a new AI model after a data leak exposed its existence. The company says early acces...
This deep-dive analyzes redwire (rdw) 2026 earnings potential, examining revenue outlook, contracts, and the catalyst...
Waterfront properties can deliver strong returns, but they carry unique risks. This guide explains how to build solid...
Rocket Lab stock has hit an all-time high, but savvy investors know a rally is more than a headline. This guide break...
Starting July 2026, the federal loan cap for professional programs changes how families fund education. Clark Howard’...
CFO Mandy Fields shifts to lead e.l.f. Beauty's AI strategy, anchoring governance, commerce readiness and efficiency ...